Ascentage Pharma Group (NASDAQ:AAPG) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.44) by 27.27 percent. This is a 33.33 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $44.541 million which beat the analyst consensus estimate of $24.070 million by 85.05 percent. This is a 36.53 percent increase over sales of $32.623 million the same period last year.